Agilent Technologies Inc vs Funko Inc — how do they compare? Agilent Technologies Inc trades at $149.35 (market cap $42.00B), while Funko Inc trades at $6.23 (market cap $346.61M). The key difference: Agilent Technologies Inc is far larger — about 121.2× Funko Inc's market cap, and Agilent Technologies Inc pays a 0.69% dividend while Funko Inc pays none. Which is the better fit depends on your goals.
| A | FNKO | |
|---|---|---|
Market Cap | $42.00B | $346.61M |
Sector | Health | Consumer Staples |
52-Week High | $157.20 | $6.35 |
52-Week Low | $110.24 | $2.65 |
Enterprise Value | $43.55B | $567.26M |
Dividend Yield | 0.69% | — |
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $145.97, up 3.28% in the last session, with a bullish technical outlook from moving averages but overbought RSI levels. The company reported strong Q1 2026 earnings, beating estimates with EPS of $1.49, and maintains solid profitability with a net income margin of 19.55%. Recent developments include FDA and EU approvals for diagnostic assays and the acquisition of Biocare Medical, enhancing its healthcare portfolio.
The stock offers upside to the consensus price target of $154.90, supported by analyst optimism (77.5% buy ratings), but high valuation ratios like a P/E of 146.56 pose risks. Investors should monitor execution of growth initiatives and competitive pressures in the life sciences sector, with earnings on August 26, 2026, as a key catalyst.
Funko (FNKO) trades at $5.88, up 11.36% today, with strong technical momentum showing bullish signals across moving averages and oscillators. The company reported improved Q2 2026 results with net sales up 7% to $207.7 million and raised adjusted EBITDA guidance, though full-year 2025 showed a net loss of $67.36 million on $908.21 million revenue. Analyst sentiment is mixed with 42.9% buy ratings, while institutional ownership remains stable.
The outlook suggests potential recovery with recent earnings beats and strategic hires, but risks include persistent negative margins, high debt levels at 32.89% debt-to-asset ratio, and competitive pressures in the collectibles market. Valuation appears reasonable with P/S of 0.35 and EV/EBITDA of 6.41, offering upside if turnaround continues.
Trailing returns across standard periods
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →Funko Inc is a US-based pop culture consumer products company. It creates whimsical, fun, and different products which enable the customer to express their affinity for their favorite through movie, TV show, video game, musician or sports team. The company holds licenses and the rights to create tens of thousands of characters including Game of Thrones, Walking Dead, Disney, Marvel, Harry Potter, Fallout, and others. Its products include Pop, Dorbz, Mystery Vinyl, Plush, Action Figures, and Others. The company sells its products through a diverse network of retail customers across multiple retail channels, including specialty retailers, mass-market retailers, and e-commerce sites.
Read more on FNKO →